Drug Delivery Systems to modulate ADME of therapeutic agents
Development of controlled and targeted drug delivery systems to modulate the pharmacokinetics (ADME) of the drugs is one of the research objectives of IDBR. This is a broad area which covers several routes of drug delivery such as oral, transdermal, transmucosal, parenteral and trans-ocular. In this direction, the matrix and barrier controlled systems, soft matter systems and nanotechnology based products are being researched at IDBR. The research could potentially have significant impact on the quality of life of patients suffering with chronic diseases such as chronic pain, asthma, infections and cancer.